Albertsons Agrees to $774 Million Opioid Settlement Amid National Litigation Efforts
Albertsons Companies has reached a $774 million settlement to resolve opioid-related claims brought by state, local, and tribal governments across the United States. This settlement is part of a broader legal effort to hold pharmacy chains accountable for their role in the opioid crisis. The claims allege that Albertsons, along with other major pharmacy retailers, dispensed large volumes of opioid prescriptions despite warning signs, contributing to widespread addiction and community harm. Although Albertsons has not admitted liability, the financial impact of the settlement has been reflected in the company's recent earnings, which showed a quarterly loss due to opioid-related charges. This agreement aligns Albertsons with other major pharmacy chains like CVS, Walgreens, and Walmart, which have collectively paid billions in similar settlements. 
